Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty-Reference-Cited by-同舟云学术

Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty

Published:2017-11 Issue:11 Volume:32 Page:3524-3528.e1
ISSN:0883-5403
Container-title:The Journal of Arthroplasty
language:en
Short-container-title:The Journal of Arthroplasty

Author:

Cafri Guy,Paxton Elizabeth W.,Chen Yuexin,Cheetham Craig T.,Gould Michael K.,Sluggett Janet,Bini Stefano A.,Khatod Monti

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine

Reference34 articles.

1. National Hospital Discharge Survey: 2010 table, procedures by selected patient characteristics - number by procedure category and age;Centers for Disease Control and Prevention,2013

2. Does Aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?;Bozic;J Arthroplasty,2010

3. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines;Falck-Ytter;Chest,2012

4. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition);Geerts;Chest,2008

5. Prevention of pulmonary embolism and deep vein thrombosis with low dose Aspirin: Pulmonary Embolism Prevention (PEP) trial;Lancet,2000

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin for thromboembolic prophylaxis EMERGING FROM THE UNCERTAIN WORLD OF OBSERVATIONAL EVIDENCE;BONE JOINT J;2024

2. Aspirin for thromboembolic prophylaxis;The Bone & Joint Journal;2024-07-01

3. Prediction model of deep vein thrombosis risk after lower extremity orthopedic surgery;Heliyon;2024-05

4. Aspirin or enoxaparin for VTE prophylaxis after primary partial, total or revision hip or knee arthroplasty: A secondary analysis from the CRISTAL cluster randomized trial;PLOS ONE;2024-04-16

5. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients;The Journal of Arthroplasty;2023-08